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Abstract
Background: Varicella is a common childhood disease. Only 5% of first varicella-zoster-virus infections occur
asymptomatically. Most data on the burden of varicella stem from health service databases. This study aims to
provide insight in the burden of varicella from a parent’s perspective including cases outside the healthcare
system.
Methods: An internet questionnaire was developed for parents in the Netherlands to report health care resource
use and productivity losses during the varicella episode in their child younger than 6 years. 11,367 invitations were
sent out to members with children of an internet panel of a market research agency. 4,168 (37%) parents started
the questionnaire (response rate), of which 360 (9%) stopped before completion and 1,838 (44%) were out of the
target group. In total 1,970 parents completed the questionnaire. The questionnaire provided a symptom list
ranging from common symptoms, such as skin vesicles, itching to fits or convulsions. A posteriori, in the analyses,
the symptoms ‘skin infections’, ‘fits/convulsions’, ‘unconsciousness’, and ‘balance and movement disorders’ were
labelled as complications. There was no restriction to time since the varicella episode for inclusion in the analyses.
Results: The 1,970 respondents had in total 2,899 children aged younger than six years, of which 2,564 (88%)
children had had varicella. In 62% of the episodes the parent did not seek medical help. In 18% of all episodes
symptoms labelled as complications were reported; in 11% of all episodes parents visited a medical doctor (MD)
for a complication. Reporting of complications did not differ (X
2 ; p = 0.964) between children with a recent (≤ 12
months ago) or a more distant (> 12 months) history of varicella. Prescription drugs were used in 12% of the
children with varicella; OTC drugs in 72%. Parents reported work loss in 17% of the varicella-episodes (23% when
MD visit; 14% when no MD-visit) for on average 14 hours, which equals to 2.5 hours of work loss for any given
varicella-episode.
Conclusions: This study shows the full spectrum of varicella-episodes and associated healthcare use, including the
large proportion of cases not seeking medical care and the societal impact associated with those cases.
Background
Varicella is a common childhood disease. The seroposi-
tivity increases sharply with age from 18% for both
0- and 1-year-olds, to 49%, 59%, 76% and 93% for 2-, 3-,
4- and 5-year-olds, respectively [1]. Only about 5% of
first varicella-zoster-virus (VZV) infections occur
asymptomatically [2]. The contagious period lasts from
1-2 days before up to 5-7 days after appearance of the
rash [3]. Varicella usually is an uncomplicated, self-
limiting disease. However, serious complications leading
to hospitalisation and, sometimes, death do occur. In
the Netherlands, the general practitioner (GP) consulta-
tion rate (all ages) for varicella is 253 per 100,000 popu-
lations leading to an estimated 40,000 visits to the GP.
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deaths each year on a population of 16 million [1].
Universal vaccination for varicella has been introduced
in several developed countries (e.g. Germany, Australia,
Japan, Canada and the United States), showing dramatic
decline of disease incidence in the latter [4]. In the Nether-
lands the decision to include varicella in the national
immunisation vaccination programme is pending. The
main points of uncertainty relate to the impact of varicella
vaccination on the incidence of zoster infections later in
life [5], and uncertainty related to the burden of complica-
tions following varicella infection, and the indirect non-
medical costs associated with varicella [2]. Most data we
have on the burden of varicella stem from hospital data
and GP-databases. However, the Netherlands is known for
more conservative health seeking behaviour as compared
to other European countries. The GP contact rate is only
lower in Finland and Greece [6].
Hence we will miss a considerable burden of varicella
in the population when we look at health service based
data, because not all of the parents will seek medical
help. We acknowledge that those cases can be expected
to be mild, but they still might have an impact on
society through work loss by the parents.
The aim of this study is to provide insight in the burden
of varicella from a parent’s perspective. We will describe
the frequency of symptoms, including complications, the
use of medical resources, and the societal impact including
cases, which do not enter the healthcare system.
Methods
Questionnaire and Study Population
We developed a questionnaire retrospectively asking par-
ents about symptoms, health care use and productivity
losses related to the most recent episode experienced of
varicella of one of their children younger than six years.
The domains covered by the questionnaire included back-
ground information on the parent and family (e.g. age,
education, number of children in the family) characteris-
tics of the disease episode (symptoms and complications,
duration, frequency), the use of medical resources (num-
ber of physician and emergency room (ER) visits, tele-
phone consultations, hospitalisations, prescription and
over-the-counter (OTC) drug use including zero use; diag-
nostic tests and surgical interventions were not included),
and productivity loss by the caregivers (work days lost,
loss of productivity at work, loss of leisure time). The
questionnaire was sent electronically to a sample of par-
ents with young children from the Netherlands, who parti-
cipated in an Internet access panel of Survey Sampling
International (SSI), a market research agency in Rotter-
dam, the Netherlands. Children under six years were
included in the analyses, matching the age-specific inci-
dence of chickenpox in the Netherlands. The panel, which
consists of people who have elected to participate in
surveys sent out by SSI on behalf of its clients, is a general
consumer panel, not specifically set up for health-related
subjects. There was no financial incentive specifically
related to this internet survey, but SSI donates a small
amount to charity for every complete questionnaire
returned, and there is a prize draw with small prizes for
the participants. It was technically impossible for respon-
dents to complete the questionnaire more than once. In
total 11,367 invitations were sent out by SSI to panel
members with children, of which 4,168 (37%) started the
questionnaire (the response rate). Of the people who
started the questionnaire 360 (9%) stopped and 1,838
(44%) were out of the target group. In total 1,970 parents
completed the questionnaire. SSI collects information
about their panel members such as family composition,
including age of the children. However this information is
not always complete (e.g. SSI only knows the panel mem-
ber has children, but does not know the age) or can be out
dated. The questionnaire contained questions to check if
the respondent was eligible for the study. If not, they were
screened out.
The questionnaire included questions on education and
geographical distribution. The demographics of the sample
showed that the geographical distribution of the respon-
dents was representative of the population in the Nether-
lands. The indicator of socio-economic status (education)
was slightly higher in this survey (low education 15%,
medium 50%, high 35% versus low 29%, medium 46% and
high 25% in the Dutch population (all differences being
significant due to large numbers for the Dutch popula-
tion). The mean number of children of the respondents
(1.5 children) was comparable with the Dutch population
(1.7 children).
Parents were asked to provide details about the most
recent varicella episode of their young child (under six
years of age). When they had more than one child under
the age of six, they were asked to complete the question-
n a i r ef o ra l lc h i l d r e n .A l ld a t aw e r es e l f - r e p o r t e db yt h e
parents.
There was no restriction to time since the varicella epi-
sode to be included in the results. Thus the varicella epi-
sode could have been little less than six years prior to the
questionnaire at a maximum. However, questions related
to productivity loss were only presented to parents with
children who had varicella up to and including 12 months
ago. As a consequence, data on work absenteeism and
productivity loss, and leisure time loss were based on a
subsample of 904 children with a recent (i.e. ≤12 months)
history of varicella. Questions on the frequency and type
of symptoms, including complications, were addressed to
the whole sample. The questionnaire was field tested by a
small group (n = 10) of parentst oi d e n t i f yp o s s i b l eg a p s
and unclear phrasing of the questions. The parents
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online. They were subsequently interviewed about the fea-
sibility of the questionnaire. The Internet survey was sent
out and completed in June 2008.
The questionnaire provided a symptom list ranging
from common symptoms of varicella, such as skin vesi-
cles, itching, fever, troubled sleeping, and skin infection
to fits or convulsions. Parents were asked to indicate
whether their child had one or more of the symptoms
listed and whether they had visited a medical doctor for
one of these symptoms. Parents were asked to report all
the health care services used related to the varicella epi-
sode including physician visits, ER visits, hospitalisations,
prescription drugs, and OTC drugs (diagnostic tests and
surgical interventions were not included). A posteriori, in
the analyses, we labelled ‘skin infections’, ‘fits/convul-
sions’, ‘unconsciousness’,a n d‘balance and movement
disorders’ as complications.
Indirect Resource Use (Productivity Losses)
Productivity losses included hours of absence from a paid
or unpaid job, as well as loss of productivity at work and
loss of hours of leisure time. Absence from an unpaid job
was defined as not being able to (1) provide usual informal
care to others; (2) carry out any other voluntary work; or
(3) carry out activities around the house [7]. To investigate
loss of productivity at work, we asked whether the parents
felt less productive during work because of their child’si l l -
ness (e.g., because they could not concentrate properly). If
so, parents with a paid job were asked to estimate how
many extra hours they would have needed to be as pro-
ductive as when their child was not ill. This question has
shown to yield conservative results for loss of productivity
at work [8]. Loss of leisure time was defined as any time
during free weekdays or weekends that was spent at a phy-
sician or pharmacy visit because of the child’s illness. The
parent who filled out the questionnaire was asked to fill
out any productivity loss hours for their partner, the
child’s grandparents, or other informal caregivers as well.
For each type of productivity loss hours (absence from
work, loss of productivity at work, and loss of leisure
time), the hours lost are presented for all informal care-
givers combined (i.e., the total hours missed due to the
disease episode).
The questionnaire was developed by the authors of this
paper and programmed by SSI in close collaboration
with the authors. In developing the questionnaire, both
the Productivity and Disease Questionnaire (PRODISQ)
[9] and the Health and Labour Questionnaire (HLQ) [10]
were studied, and relevant items on productivity losses
were included in the survey questionnaire. We did not
use PRODISQ or HLQ because these questionnaires
were developed to measure productivity loss due to
health problems in the working adults and contain many
items not relevant to our study.
Statistical analyses
The data were mainly categorical. The data-analysis was
descriptive. Results were addressed in terms of absolute
numbers, percentages, means, standard deviations, med-
ians, 95% confidence intervals and ranges. Chi-square ana-
lyses and Mann-Whitney tests were used to test for
statistical differences between groups when the data
allowed such comparisons. Data were analysed using SPSS
for Windows version 14.0.
Results
Study population and symptoms
T h er e s p o n s er a t eo ft h eq u e s t i o n n a i r ew a s3 7 % .D a t a
were available for 1,970 respondents (mean age 35.5 years;
82% female respondents) with in total 2,899 children aged
younger than six years, of which 2,564 (88%) children
reported a history of varicella. Table 1 provides informa-
tion on the characteristics of the children with a history of
varicella. In 35% (n = 904) of cases the time elapsed
between the disease episode and filling out the question-
naire was shorter than or equalled 12 months. The mean
age of these children (2.7 years (SD 1.5) was younger than
for those who had had varicella over one year ago (4.8
years SD 1.0). The most frequent symptoms of varicella
were skin vesicles (98%), itching (92%), listlessness (91%)
and fever (78%). In 472 children (18%) one or more symp-
toms that can be seen as complications were reported by
the parents; 411 children (16%) with skin infection or
inflammation, 115 children (5%) with balance or move-
ment disorders, 85 children (3%) with fits/convulsions and
65 children (3%) with unconsciousness (Table 2).
In 973 children with an episode of varicella the parents
sought medical care (Table 2). When we only take into
account the complications for which the parents visited a
medical doctor there were 278 children (11% of total
reported episodes) with complications; 10% skin infec-
tions, 3% balance or movement disorders, 2% fits/convul-
sions and 2% unconsciousness.
As expected, all symptoms, except for itching, were sig-
nificantly more present in children who visited a medical
doctor. Symptoms that can be seen as complications, such
as skin infections, fits/convulsions, balance and movement
disorders, and unconsciousness were two to three times as
present among children who visited a medical doctor than
those who did not (Table 2). The prevalence of symptoms
did not differ among the younger (0-3 years) and older (4-
5 years) children. The rate of complications of varicella
was relatively stable in one-year age groups, ranging from
18% in one-year olds to 19% in five-year olds. The compli-
cation rate in children younger than one year was lower
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cally significant differ (Chi-square test; p = 0.964) between
children with a recent history (≤ 12 months ago) of vari-
cella and those who had varicella more than one year ago
(e.g. skin infection respectively 16% versus 16%; convul-
sions 3% versus 4%).
T h em e a nd u r a t i o no fa ne p i s o d eo fv a r i c e l l aw a s8 . 4
days (SD 4.5 days) and was significantly higher in
children who consulted any medical doctor (9.3 days
versus 7.8 days) (Mann-Whitney test; p = 0.000).
Health care use
Only 38% (n = 973) of the parents consulted a physician
when their child was ill with varicella. The percentage phy-
sician consultations was lower among children without
complications (33%; n = 686) than with complications
Table 1 Characteristics of children < 6 years of age with history of varicella, the Netherlands, 2007
N (%)
Total with history of varicella 2,564 (100)
Gender; girls 1,236 (48.2)
Mean age ± SD in years (range) 4.0 ± 1.3 years (range 0.2-5.9)
Age groups (in years)
0 55 (2.1)
1 198 (7.7)
2 341 (13.3)
3 521 (20.3)
4 704 (27.5)
5 745 (29.1)
Time elapsed at survey since varicella episode
Currently ill 55 (2.1)
Last month 88 (3.4)
2-5 months ago 331 (12.9)
6-12 months ago 430 (16.8)
1-2 years ago 719 (28.0)
More than 2 years ago 941 (36.7)
Mean age ± SD in years (range) history of varicella ≤ 12 months (n = 904) 2.7 ± 1.5 years (range 0.2-5.9)
Table 2 Symptoms during an episode of varicella* in children < 6 years of age, the Netherlands, 2007
No medical doctor’s visit (n = 1,591) Medical doctor’s visit (n = 973) 0-5 years (n = 2,564)
N (%) N (%) N (%)
Symptoms
Skin vesicles
¥ 1,552 (97.5) 964 (99.1) 2,516 (98.1)
Itching
‡ 1,452 (91.3) 905 (93.0) 2,357 (91.9)
Listlessness
¶ 1,417 (89.1) 908 (93.3) 2,325 (90.7)
Fever
¶ 1,167 (73.4) 830 (85.3) 1,997 (77.9)
Troubled sleeping
¶ 941 (59.1) 706 (72.6) 1,647 (64.2)
Troubled eating or drinking 785 (49.3) 619 (63.6) 1,404 (54.8)
Cold/coughing
¶ 647 (40.7) 551 (56.6) 1,198 (46.7)
Mouth vesicles
¶ 574 (36.1) 457 (47.0) 1,031 (40.2)
Skin haemorrhage
¶ 530 (33.3) 439 (45.1) 969 (37.8)
Diarrhoea
¶ 390 (24.5) 421 (43.3) 811 (31.6)
Vomiting
¶ 210 (13.2) 261 (26.8) 471 (18.4)
Skin infection or inflammation
¶ 168 (10.6) 243 (25.0) 411 (16.0)
Balance or movement disorder
¶ 37 (2.3) 78 (8.0) 115 (4.5)
Fits/convulsions
¶ 31 (1.9) 54 (5.5) 85 (3.3)
Unconsciousness
† 27 (1.7) 38 (3.9) 65 (2.5)
Other symptoms
¶ § 8 (0.5) 37 (3.8) 45 (1.8)
* More than one symptom or complication could be filled out; ¶ Chi-square test, p = 0.000; † Chi-square test, p = 0.001;
¥ Chi-square test, p = 0.006; ‡ Chi-square test, p = 0.115; § Broad range of complaints (e.g. asthma, otitis, laryngitis, conjunctivitis, cystitis, dehydration)
Wolleswinkel-van den Bosch et al. BMC Infectious Diseases 2011, 11:320
http://www.biomedcentral.com/1471-2334/11/320
Page 4 of 9(61%; n = 287) (Chi-square test; p < 0.05). In most cases
the consultation was a face-to-face consultation with a GP
during weekdays and/or a telephone consultation (Table 3).
There was no difference in the proportion visiting a medical
doctor between the age groups 0-3 years and 4-5 years.
According to the parents, the occurrence of skin vesicles
was the most important reason to consult a GP or specialist
care (43%), followed by itching (20%) and fever (19%)
(results not shown).
Sixty-one per cent (n = 288) of the cases with one or
more complications visited a medical doctor and, 32%
received a prescription drug (Table 3). This pattern was
largely similar for all complications separately as well.
The medical visit rate was highest among children with
balance and movement disorders, 68%.
Seventeen children (1%) were hospitalized for the
symptoms and/or complications of varicella, for a mean
duration of 6.7 days (SD 5.6; range 1-21 days). As
expected, the hospitalization rate was significantly higher
in children with complications (overall 3%; 9% in cases
with unconsciousness and 5% in cases with convulsions).
Children who were hospitalized had combinations of dif-
ferent symptoms and/or complications of varicella. The
most important symptoms leading to hospitalization
were fever (47%), unconsciousness (35%), skin infections
(29%) and fits/convulsions (24%). Seven children were
hospitalized due to frequently reported complications of
varicella such as asthma, pneumonia, and otitis of both
ears [11].
Use of prescription drugs was reported in 12% of the
children with varicella (n = 310), being considerably
higher in children with complications (Table 3). In 72%
of all children with an episode of varicella OTC drugs
were bought. In that case there was no difference
between children with or without complications. Parents
who visited a medical doctor bought slightly more often
OTC drugs for their child with varicella (76%) compared
with parents who did not visit a medical doctor (70%).
Productivity loss
Of the 2,564 children with varicella, 1,749 children
attended school or any form of day care including home
care or staying with family members. Varicella caused
a b s e n c ef r o ms c h o o lo rd a yc a r ei n5 7 %o ft h ec h i l d r e n
(65% in children visiting a medical doctor; 52% in those
who did not) who visited school or any form of day care.
The mean duration of the absence was 4.1 days (SD 3.5
days) and the absence was significant longer in children
who consulted a medical doctor (mean 4.8 days versus 3.5
days) (Mann-Whitney test; p = 0.000).
P a r e n t sr e p o r t e dt i m el o s tf r o map a i dj o bi n1 7 %o f
the varicella-episodes. When hours were lost, this was
on average 14.3 hours (hours of all caregivers com-
bined). Caregivers who consulted a GP or specialist care
Table 3 Health care use during an episode of varicella in children < 6 years of age, the Netherlands, 2007
Children without complications
(n = 2,092)
Children with one or more
complications (n = 472)
All children (n = 2,564)
N (%) Mean number of
consultations (range)
N (%) Mean number of
consultations (range)
N (%) Mean number of
consultations (range)
GP telephone consultation 324 (15.5) 1.1 (1-3) 119
(25.2)
1.2 (1-4) 443 (17.3) 1.1 (1-4)
GP visit (not during weekend/
night)
344 (16.4) 1.1 (1-5) 179
(37.9)
1.2 (1-10) 543 (21.2) 1.1 (1-10)
GP visited during weekend 22 (1.1) 1.0 (1-2) 27 (5.7) 1.2 (1-5) 49 (1.9) 1.1 (1-5)
GP visit during night 4 (0.2) 1.0 (1-1) 4 (0.8) 1.0 (1-1) 8 (0.3) 1.0 (1-1)
GP home visit 3 (0.1) 1.3 (1-2) 12 (2.5) 1.6 (1-3) 15 (0.6) 1.5 (1-3)
Visit emergency department 8 (0.4) 1.1 (1-2) 25 (5.3) 1.2 (1-3) 33 (1.3) 1.2 (1-3)
Consultation specialist care 6 (0.3) 1.2 (1-2) 14 (3.0) 1.6 (1-5) 20 (0.8) 1.5 (1-5)
No medical doctor’s consultation 1406
(67.2)
185
(39.2)
1,591
(62.1)
Medical doctor’s consultation 686 (32.8) 287
(60.8)
973 (37.9)
Hospitalizations 3 (0.1) Mean duration: 4.7
days
14 (3.0) Mean duration: 7.1
days
17 (0.7) Mean duration 6.7
days
Drugs prescribed 161 (7.7) 149
(31.6)
310 (12.1)
Antibiotics 55 (2.6) 82 (17.4) 137 (5.3)
Other drugs 106 (5.1) 67 (14.2) 173 (6.7)
OTC drugs 1501
(71.7)
355
(75.2)
1,856
(72.4)
All differences statistically significant (Chi-square test, p < 0.05)
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givers who did not consult a medical doctor (23% versus
14%). Their absence duration was also higher; on aver-
age 17.3 hours versus 11.1 hours (Chi-square test; p =
0.000) (Table 4).
Because in the majority of cases no absence from work
was reported, the average work loss per varicella-episode
(regardless of parental work loss involved) equals to
2.5 hours of work lost (4 hours for episodes with and
1.6 hours for episodes without consultation of a medical
doctor). The main reason why parents did not need to
take hours off from their paid job was the ability to switch
work days with free week days.
Leave of absence from an unpaid job was reported less
often but the hours taken off were longer.
We also asked parents about impaired productivity at
work, due to lack of sleep or worry about their child’s ill-
ness. Parents who visited a doctor reported more fre-
quently a loss of productivity at work than parents that
did not consult a medical doctor for their child with vari-
cella (11% versus 6%) (Chi-square test; p = 0.009). How-
ever, the average amount of hours lost was significantly
less in parents who consulted a medical doctor: 6.7 hours
versus 7.8 hours (Mann-Whitney test; p = 0.01) (Table 4).
Many parents reported that some free time, about
2 hours, was spent on a physician or pharmacist visit (39%).
Discussion
This study provides insight in the medical burden of vari-
cella from a parent’s perspective and in addition also on
the impact on work absenteeism and productivity loss at
work.
Only 38% of the parents visit a medical doctor due to
symptom or complication. The whole range of symptoms
associated with varicella was more present among chil-
dren of parents who visited a medical doctor. On average
there were about 4 hours of work lost per varicella epi-
sode when parents had visited a medical doctor, and
about 1.6 hours when they did not. Parents report more
symptoms than what we know from GP databases.
The results of this study were based on an Internet panel
survey on varicella, with a ‘response rate’ of 37%. Although
this seems rather low, it should be kept in mind that this
is not a classic response rate as it depends on how well the
parents with young children could be targeted by the mar-
ket research agency. This depends on the background data
available at the market research agency. When this back-
ground is incomplete, a larger, less targeted wave of invita-
tions is sent out, which will result in relatively low
response rates.
The mean age of the parents who filled out the ques-
tionnaire was 36 years (SD 5 years) - in line with expected
ages of parents with children under six years old. This age
group is very Internet-literate in the Netherlands with 86%
of 25-54 year olds using the Internet at least once a week
[12]. In most cases the mother was the respondent (82%),
but we explicitly asked the respondent to fill out the data
on productivity loss for other possible caregivers (e.g.
father or grandparents) as well. The demographics of the
sample showed that the geographical distribution of the
Table 4 Key results on societal impact of varicella in children < 6 years of age in the Netherlands, 2007
No consultation of medical doctor
(n = 550)
Consultation of medical doctor
(n = 354)
Total
(n = 904)
Paid job
Number of children for which caregiver(s) had to stay
home n (%)
76 (13.8) 80 (22.6) 156 (17.3)
Mean absence ± SD in hours (range)* 11.1 ± 7.9
(1-40)
17.3 ± 14.3
(1-60)
14.3 ± 12.0
(1-60)
Unpaid job
Number of children for which caregiver(s) had to stay
home n (%)
31 (5.6) 20 (5.6) 51 (5.6)
Mean absence ± SD in hours (range)* 17.8 ± 20.2
(1-90)
22.1 ± 26.1
(1-100)
19.2 ± 22.2
(1-100)
Productivity loss at work**
Number of parents reporting productivity loss n (%) 34 (6.2) 39 (11.0) 73 (8.1)
Mean productivity loss ± SD in hours (range)* 7.8 ± 9.3
(1-40)
6.7 ± 6.0
(1-30)
7.2 ± 7.7
(1-40)
Leisure time loss***
Number of parents reporting leisure time loss n (%) 151 (27.5) 198 (55.9) 349 (38.6)
Mean leisure time loss ± SD in hours (range)* 1.5 ± 6.0
(0.1-72)
2.0 ± 3.5
(0.2-24)
1.8 ± 4.7
(0.1-72)
* In the cases with absence from paid or unpaid work, productivity loss at work or leisure time loss
** For example, due to lack of sleep because of caring for the sick child
*** Leisure time lost due to doctor or pharmacy visit
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Netherlands. The educational level of the respondents was
somewhat higher than reference data from the national
statistics (highest education 35% versus 24%). The educa-
tional and income level of the participants can influence
the outcome, as there might be a difference in use of med-
ical resources between educational levels [13]. Socioeco-
nomic status (measured as educational level and income)
might also affect employment rate or type of employment,
which could affect the results of absence from a paid job.
Comparison of results of an Internet access panel with a
probability sample (random digit dialling (RDD)) has
shown that internet responses were significantly more
likely to agree with RDD responses when the question
asked was about the respondent’s personal health (nine
times more likely than when not about their personal
health) and when the question was factual (nine times
more likely than non-factual) [14]. The questions in our
questionnaire complied largely with these characteristics.
This Internet survey showed that 88% of the respon-
dents’ children aged younger than six years had a history
of varicella. De Melker et al. reported a seroprevalence of
varicella for children aged five years of 93%, including
asymptomatic cases of varicella [1]. About 5% of first VZV
infections occur asymptomatically and this internet survey
did not include asymptomatic cases of varicella. Thus, the
prevalence of symptomatic cases in our survey is compar-
able with the seroprevalence as reported by De Melker
et al. [1].
The prevalence of symptoms reported in this study gives
an overview of the prevalence of the most common vari-
cella symptoms from a parent perspective. It shows, not
surprisingly, that almost all children have skin vesicles and
show itching. Fever occurs in about three quarters of the
children, two thirds have problems with sleeping, and
about half of the children have problems with eating or
drinking. 11% of the parents reported an episode with
complications for which they visited a medical doctor.
Parents are capable of reporting a history of varicella in
their children. Several studies have shown high positive
predictive value of 95% or more for parent reports [15,16].
The accuracy of self-reported data diminishes with time
elapsed. We asked parents to report on a varicella episode
of their children aged less than six years. We analysed
whether there were differences in the report of complica-
tions for a history of varicella up and including 12 months
and 12 months or more. There were no significant differ-
ences (Chi-square test; p = 0.964).
It is probably difficult for parents to distinguish between
a more serious course of the varicella episode and compli-
cations. Therefore we just listed mild and more serious
symptoms in the questionnaire (see Table 1) and we
labelled ‘skin infection or inflammation’, ‘balance or move-
ment disorder’, ‘fits/convulsions’,a n d‘unconsciousness’ as
complications afterwards in the analyses. Parents reported
‘complications’ in 18% of all varicella episodes irrespective
of physician visit. We used lay-men vocabulary to ask
about the more serious symptoms. As a consequence of
that, within the 18%, symptoms like ‘balance and move-
ment disorder’, ‘fits/convulsions’,a n d‘unconsciousness’
will probably include mild presentations of these
symptoms.
The varicella episodes with complications for which a
medical doctor had been visited probably represent the
more serious complications. This was the case in 11% of
all varicella episodes (278/2564); in 6% of all varicella epi-
sodes drugs were prescribed in an episode with complica-
tions (149/2564). Those percentages fit in the range of
data on complications of varicella published elsewhere.
The complication rate in varicella in primary care ranges
from 2% to 15% in other published data [2,17-23].
Although those other studies are primary care based and
our study is population based, we believe that this com-
parison is justified. Health care use is much higher in
other European countries in mild childhood diseases as
compared with the Netherlands. In the Netherlands, for
any given disease-episode in young children 47% of the
parents visit a medical doctor, whereas this is 79% in
Germany, 89% in Spain, 86% in France and 87% in Italy
[24]. In other words, it is likely that in other countries
less serious cases present at primary care as well, con-
trary to the Netherlands.
Another factor that should be taken into account to
appreciate the results of the Internet survey is that the
results are based on parent reports which might result in
a higher prevalence estimate as compared with primary
care based studies. GP’s or paediatricians might only
record what they consider the primary symptom for
which parents came for a consultation, while parents
have likely reported all symptoms they remembered
about the disease episode. This might, for example,
include relatively minor skin infections that a GP would
normally not record. In addition, children are infected
with varicella-zoster-virus early in life in the Netherlands
(50% seroconversion by age two), as compared to for
example Germany (50% seroconversion by age four).
This might also affect the complication rate and explain
differences in complication rate between countries.
Other factors that explain differences in complication
rates among publications are the complications included
e.g. dehydration from vomiting or diarrhoea, exacerba-
tion of asthma, pneumonia, bacterial super infections,
acute neurological disorders, bronchitis and otitis media,
conjunctivitis and corneal infections, central nervous
system injuries and stomatitis. Studies differ also in age
groups included (e.g. up to 14 years or under 4 years),
and whether or not immunocompromised children are
included [2].
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led to admission of the child. Although the number of
hospitalized children was low (n = 17), the distribution of
symptoms seems more comparable with published data.
For example, in Germany, febrile convulsions were present
in 30% of the hospitalized children < 16 years in the pre-
immunization era [25], and skin infections in 23% [26].
Super infections of the skin occurred in 37% of hospita-
lized children in a French study [27]. Neurological compli-
cations were reported in about one quarter of hospitalized
cases in a French and German study [25,28].
Data on health care use of mild childhood diseases, and
specifically the percentage of children not seeking medical
care are scarce. Our results on health care use could be
compared with a postal survey among parents of children
aged 2-6 years in the Netherlands in 1998 [29]. IThe postal
survey relates to all kinds of childhood diseases. In our
study, parents did not seek medical help for 62% of the
disease episodes, compared to 50% in the postal survey.
There had only been telephone contact with a GP in 17%
versus 23% of the disease episodes in respectively the
Internet and postal survey. Use of OTC drugs was
reported in the Internet survey for 72% and in the postal
survey for 64% of the episodes. Results from another Inter-
net survey indicated that 53% of the children with symp-
toms of otitis media did not consult a medical doctor in
the Netherlands [24].
The hospitalization rate of 0.7% in children with vari-
cella is comparable with hospitalization rates reported in
other studies. The hospitalization rate reported by De
Melker et al for children presenting with varicella at the
GP was 0.4% for 5-9 year olds, 1.0% in 1-4 year olds and
2.7% in infants [1]. Banz et al. (2004) reported a hospitali-
zation rate for cases with varicella or an associated com-
plication of 0.8% in Germany [11]. He referred in the
same article to other published data indicating that in the
United States between 0.1% and 0.6% of children are
admitted to hospital as a result of varicella or an asso-
ciated complication, while data from Canada suggest a
somewhat higher hospitalization rate for children during
an acute episode of varicella, ranging between 0.2% and
1.5%, and in France about 0.5% of all varicella patients
need hospital care due to severe complications [11].
To reduce recall bias, questions on societal impact (e.g.
work absenteeism) were only asked about varicella epi-
sodes that had occurred up to and including 12 months
ago; half of the varicella episodes had occurred up to 6
months ago. Results for work absenteeism (Table 4) are
comparable with other studies. Seventeen per cent of the
parents needed to take time off from work to care for
their child. It has previously been estimated from a
Dutch community study on costs of gastroenteritis that
15% of the parents had to miss work for a child’s episode
of rotavirus diarrhoea [30,31]. A review study on
economic evaluations of varicella vaccination pro-
grammes has reported numbers of working days lost for
a common case of varicella of 1.2 in Spain, 0.6 in France
and 2.6 in Germany (adjusted for caregivers outside the
labour market) [32]. Other studies have reported 0.6 to
3.7 working days missed for any uncomplicated case of
varicella [11,33,34]. Results for the Netherlands (0.5 days
for episodes with and 0.2 days for episodes without con-
sultation of a medical doctor) are at the low end of this
range, which can probably be explained by a high-pro-
portion of part-time work (80% among women) in the
Netherlands [35].
Conclusions
In sum, this study provides insight in the full spectrum of
varicella-episodes and associated healthcare use, which is
of interest for an infectious disease that infects virtually all
young children. In addition, insight in the proportion of
cases not seeking medical care and the societal impact
associated with those cases gives valuable information for
the cost-effectiveness analyses on vaccine introduction in
the Netherlands. This study shows the otherwise not visi-
ble burden of disease outside the healthcare system, which
is of particular importance in countries with conservative
health seeking behaviour.
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